Digital Breast Tomosynthesis Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems), By End-User (Hospitals, Diagnostic Centers, Other End-Users) Region and Competition, 2019-2029F
Global Digital Breast Tomosynthesis Equipment Market was valued at USD 3.02 billion in 2023 and is anticipated t%li%project robust growth in the forecast period with a CAGR of 9.89% through 2029. The Global Digital Breast Tomosynthesis Equipment Market is a dynamic landscape characterized by innovation, technological advancements, and a growing emphasis on early detection and precise diagnosis of breast cancer. Breast tomosynthesis, als%li%known as 3D mammography, has revolutionized breast imaging by offering improved visualization of breast tissue compared t%li%traditional 2D mammography. This market has witnessed significant growth driven by factors such as increasing incidences of breast cancer, rising awareness about the importance of early detection, and advancements in imaging technology. As healthcare systems worldwide prioritize preventive care and personalized treatment approaches, digital breast tomosynthesis has emerged as a crucial tool in the arsenal against breast cancer. The market encompasses a wide range of equipment, including digital breast tomosynthesis systems, software solutions for image processing and analysis, and associated accessories. Key players in this market are continuously investing in research and development t%li%enhance the capabilities of their products, focusing on features like improved image resolution, faster scan times, and enhanced workflow efficiency.
Technological advancements play a pivotal role in shaping the digital breast tomosynthesis equipment market, with innovations such as 3D-guided biopsy systems, artificial intelligence (AI)-powered image analysis software and improved ergonomic designs enhancing diagnostic accuracy and patient comfort. These advancements not only facilitate early detection of breast cancer but als%li%enable healthcare providers t%li%offer more personalized and precise treatment strategies. Furthermore, the integration of digital breast tomosynthesis with other imaging modalities such as ultrasound and magnetic resonance imaging (MRI) is fostering a multimodal approach t%li%breast cancer diagnosis, allowing for comprehensive evaluation and better patient outcomes.
Key Market Drivers
Rising Incidence of Breast Cancer
The rising incidence of breast cancer is a significant driver behind the growth of the global digital breast tomosynthesis equipment market. Breast cancer remains one of the most common types of cancer among women worldwide, with millions of new cases diagnosed each year. Factors such as aging populations, lifestyle changes, and increased awareness leading t%li%more screenings contribute t%li%the rising incidence rates.
As the number of breast cancer cases continues t%li%climb, there is a growing emphasis on early detection as a crucial factor in improving survival rates and treatment outcomes. Digital breast tomosynthesis (DBT) offers several advantages over traditional 2D mammography, including improved sensitivity and specificity in detecting breast abnormalities. The ability of DBT t%li%provide three-dimensional images of breast tissue helps radiologists identify lesions more accurately, reducing false-positive and false-negative results.
Healthcare providers are increasingly turning t%li%DBT equipment t%li%enhance their breast cancer screening and diagnostic capabilities. By adopting DBT technology, healthcare facilities can offer their patients a more advanced and comprehensive screening experience, leading t%li%earlier detection of breast cancer and potentially better patient outcomes. Regulatory bodies and healthcare organizations are recognizing the clinical benefits of DBT and incorporating it int%li%breast cancer screening guidelines and recommendations. This growing acceptance and endorsement of DBT as a preferred imaging modality for breast cancer detection further drive its adoption in healthcare settings worldwide.
The rising incidence of breast cancer als%li%underscores the need for continuous innovation and improvement in breast imaging technology. Manufacturers are investing in research and development t%li%enhance the performance and capabilities of digital breast tomosynthesis equipment, focusing on areas such as image resolution, workflow efficiency, and patient comfort. These advancements not only improve the diagnostic accuracy of DBT but als%li%make it more accessible and user-friendly for healthcare providers and patients alike.
Growing Emphasis on Early Detection and Screening Programs
The growing emphasis on early detection and screening programs is a key driver propelling the expansion of the global digital breast tomosynthesis equipment market. Early detection plays a critical role in improving treatment outcomes and survival rates for breast cancer patients, making it a primary focus for healthcare systems worldwide. Screening programs aim t%li%identify breast abnormalities at their earliest stages, when treatment options are most effective, and chances of survival are highest.
Digital breast tomosynthesis (DBT) has emerged as a powerful tool in breast cancer screening due t%li%its ability t%li%provide three-dimensional images of breast tissue with enhanced clarity and detail compared t%li%traditional 2D mammography. The superior sensitivity and specificity of DBT in detecting breast abnormalities contribute t%li%its increasing adoption in screening programs globally. Healthcare organizations, advocacy groups, and governmental agencies are actively promoting breast cancer screening initiatives t%li%raise awareness and encourage early detection among women. These programs often incorporate digital breast tomosynthesis technology as part of their screening protocols, offering patients access t%li%advanced imaging modalities that improve the accuracy and reliability of breast cancer detection.
The integration of DBT int%li%organized screening programs and routine clinical practice has become more widespread as healthcare providers recognize the clinical benefits of this technology. Digital breast tomosynthesis enables radiologists t%li%detect smaller lesions, identify architectural distortions, and reduce false-positive and false-negative findings, leading t%li%more accurate diagnoses and better patient outcomes. In addition t%li%traditional screening programs, there is a growing trend towards personalized screening approaches that take int%li%account individual risk factors and preferences. Digital breast tomosynthesis equipment allows for tailored screening protocols based on a patient's breast density, family history, genetic predisposition, and other relevant factors, optimizing the effectiveness of screening efforts and minimizing unnecessary interventions.
Technological Advancements in Imaging Technology
Technological advancements in imaging technology are playing a pivotal role in driving the growth of the global digital breast tomosynthesis equipment market. As the field of medical imaging continues t%li%evolve, manufacturers are constantly innovating t%li%enhance the capabilities and performance of digital breast tomosynthesis (DBT) equipment, leading t%li%improved diagnostic accuracy and patient outcomes. One of the key technological advancements driving the adoption of digital breast tomosynthesis equipment is the development of higher-resolution imaging sensors and detectors. These advancements enable DBT systems t%li%capture detailed three-dimensional images of breast tissue with greater clarity and precision, enhancing the ability of radiologists t%li%detect subtle abnormalities and lesions.
Advancements in image reconstruction algorithms and processing software have significantly improved the quality of DBT images while reducing noise and artifacts. Sophisticated reconstruction techniques such as iterative reconstruction and model-based algorithms enhance image resolution and contrast, enabling more accurate interpretation of breast images and reducing the likelihood of false-positive and false-negative findings. Another important technological advancement in DBT equipment is the integration of artificial intelligence (AI) and machine learning algorithms. AI-powered image analysis software can automatically detect and highlight suspicious areas on breast images, assisting radiologists in their interpretation and decision-making process. These AI algorithms can als%li%analyze large datasets of breast images t%li%identify patterns and trends, potentially leading t%li%the development of more precise diagnostic tools and predictive models for breast cancer detection.
Also, advancements in ergonomic design and user interface enhancements have made digital breast tomosynthesis equipment more user-friendly and efficient for healthcare providers. Streamlined workflows, intuitive software interfaces, and ergonomic features such as adjustable compression paddles improve the overall user experience and workflow efficiency, enabling radiologists t%li%perform more screenings in less time.
Key Market Challenges
High Initial Setup Costs
One of the primary challenges hindering the adoption of digital breast tomosynthesis equipment is the high initial setup costs associated with acquiring and implementing this technology. Healthcare facilities, particularly in resource-constrained settings, may face budgetary constraints that limit their ability t%li%invest in expensive imaging equipment. The cost of purchasing DBT systems, along with installation, training, and maintenance expenses, can pose a significant financial burden on healthcare providers, impeding the widespread adoption of digital breast tomosynthesis technology.
Reimbursement Issues
Reimbursement policies and coverage for digital breast tomosynthesis procedures vary across different regions and healthcare systems, leading t%li%inconsistencies and uncertainties regarding reimbursement for screening and diagnostic services. In some cases, reimbursement rates may not adequately cover the costs associated with DBT procedures, limiting healthcare providers' incentive t%li%invest in this technology. Additionally, delays or denials in reimbursement approvals can create financial challenges for healthcare facilities, discouraging them from adopting digital breast tomosynthesis equipment.
Regulatory Hurdles
Regulatory approval processes for medical devices, including digital breast tomosynthesis equipment, can be lengthy, complex, and costly. Manufacturers must adhere t%li%stringent regulatory requirements and standards set forth by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) t%li%ensure the safety, efficacy, and quality of their products. Delays in obtaining regulatory approvals or compliance with evolving regulatory requirements can significantly impact product launch timelines and market access, posing challenges for manufacturers seeking t%li%introduce new digital breast tomosynthesis technologies.
Key Market Trends
Increasing Adoption of 3D Mammography
The increasing adoption of 3D mammography is a pivotal factor driving the growth of the global digital breast tomosynthesis (DBT) equipment market. 3D mammography, als%li%known as digital breast tomosynthesis (DBT), has emerged as a preferred imaging modality for breast cancer screening and diagnosis due t%li%its superior capabilities compared t%li%traditional 2D mammography.
3D mammography provides a three-dimensional view of the breast tissue, allowing radiologists t%li%examine breast images layer by layer, thereby improving the detection of breast abnormalities, including small tumors and lesions. This enhanced sensitivity and specificity of 3D mammography in detecting breast cancer have led t%li%its widespread adoption among healthcare providers worldwide. The adoption of 3D mammography is driving the demand for digital breast tomosynthesis equipment, as DBT systems are specifically designed t%li%perform 3D mammography imaging. Healthcare facilities are investing in DBT equipment t%li%upgrade their breast imaging capabilities and offer patients access t%li%advanced screening technologies.
Moreover, the clinical benefits of 3D mammography, including improved cancer detection rates and reduced false-positive findings, are driving market growth. Studies have demonstrated that 3D mammography detects more cancers compared t%li%2D mammography alone while als%li%decreasing the number of false-positive results, leading t%li%more accurate diagnoses and reducing unnecessary follow-up procedures. Regulatory bodies and healthcare organizations are endorsing the use of 3D mammography in breast cancer screening programs, further fueling its adoption. Guidelines from organizations such as the American Cancer Society and the European Society of Breast Imaging recommend the use of DBT as part of routine breast cancer screening for certain patient populations.
Integration with Multimodal Imaging Approaches
The integration of digital breast tomosynthesis (DBT) with multimodal imaging approaches is emerging as a key driver of growth in the global digital breast tomosynthesis equipment market. Multimodal imaging combines the strengths of different imaging modalities, such as ultrasound, magnetic resonance imaging (MRI), and DBT, t%li%provide a more comprehensive evaluation of breast lesions and improve diagnostic accuracy.
By integrating DBT with other imaging modalities, healthcare providers can obtain complementary information about breast tissue morphology, composition, and vascularity, enhancing the diagnostic capabilities of DBT equipment. This integrated approach enables radiologists t%li%better characterize breast lesions, differentiate between benign and malignant lesions, and guide treatment planning.
One of the primary benefits of integrating DBT with multimodal imaging approaches is the ability t%li%overcome the limitations of individual imaging modalities. While DBT excels in detecting architectural distortions and microcalcifications associated with breast cancer, it may have limitations in visualizing certain types of lesions, such as cysts or masses with complex morphologies. By combining DBT with ultrasound or MRI, healthcare providers can obtain additional information about lesion morphology, vascularity, and tissue composition, enhancing diagnostic confidence and reducing the need for additional imaging studies. Multimodal imaging approaches enable more personalized and precise treatment planning for breast cancer patients. By incorporating information from multiple imaging modalities, healthcare providers can tailor treatment strategies based on individual patient characteristics, such as tumor size, location, and histological features. This personalized approach improves treatment outcomes and reduces the risk of undertreatment or overtreatment, leading t%li%better patient care and satisfaction.
The integration of DBT with multimodal imaging approaches als%li%streamlines the diagnostic workflow and improves efficiency in breast imaging centers. Rather than performing separate imaging studies using different modalities, healthcare providers can perform comprehensive evaluations using a single imaging session, saving time and resources for both patients and providers.
Segmental Insights
Product Type Insights
Based on the product type, therapeutics segment emerged as the dominant segment in the global digital breast tomosynthesis equipment market in 2023. This is primarily due t%li%the combined benefits offered by both 2D and 3D mammography technologies, making it a preferred choice among healthcare providers and patients alike. 2D mammography has been the standard screening tool for breast cancer detection for many years, offering reliable results and widespread availability. However, it has limitations, particularly in detecting lesions in dense breast tissue and differentiating between overlapping structures. On the other hand, 3D mammography, or digital breast tomosynthesis (DBT), provides a three-dimensional view of the breast tissue, allowing for better visualization and characterization of breast lesions.
Regional Insights
North America solidified its position as the leading region in the global digital breast tomosynthesis equipment market, capturing the largest market share. This dominance can be attributed t%li%North America's robust healthcare infrastructure, characterized by advanced medical facilities and well-established breast cancer screening programs. With a high level of healthcare expenditure, the region fosters a conducive environment for the adoption of innovative medical technologies, including digital breast tomosynthesis equipment.
Healthcare providers in North America increasingly integrate digital breast tomosynthesis int%li%routine clinical practice, recognizing its effectiveness in detecting breast cancer and reducing false positives. The technology's ability t%li%provide three-dimensional images of the breast improves diagnostic accuracy and enhances the early detection of abnormalities, contributing t%li%better patient outcomes. North America's proactive approach t%li%breast cancer awareness and screening initiatives further drives the adoption of digital breast tomosynthesis equipment. Government-led campaigns and advocacy efforts raise awareness about the importance of early detection, encouraging women t%li%underg%li%regular screenings with advanced imaging technologies.
Key Market Players
In this report, the Global Digital Breast Tomosynthesis Equipment Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Digital Breast Tomosynthesis Equipment Market.
Available Customizations:
Global Digital Breast Tomosynthesis Equipment Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
Technological advancements play a pivotal role in shaping the digital breast tomosynthesis equipment market, with innovations such as 3D-guided biopsy systems, artificial intelligence (AI)-powered image analysis software and improved ergonomic designs enhancing diagnostic accuracy and patient comfort. These advancements not only facilitate early detection of breast cancer but als%li%enable healthcare providers t%li%offer more personalized and precise treatment strategies. Furthermore, the integration of digital breast tomosynthesis with other imaging modalities such as ultrasound and magnetic resonance imaging (MRI) is fostering a multimodal approach t%li%breast cancer diagnosis, allowing for comprehensive evaluation and better patient outcomes.
Key Market Drivers
Rising Incidence of Breast Cancer
The rising incidence of breast cancer is a significant driver behind the growth of the global digital breast tomosynthesis equipment market. Breast cancer remains one of the most common types of cancer among women worldwide, with millions of new cases diagnosed each year. Factors such as aging populations, lifestyle changes, and increased awareness leading t%li%more screenings contribute t%li%the rising incidence rates.
As the number of breast cancer cases continues t%li%climb, there is a growing emphasis on early detection as a crucial factor in improving survival rates and treatment outcomes. Digital breast tomosynthesis (DBT) offers several advantages over traditional 2D mammography, including improved sensitivity and specificity in detecting breast abnormalities. The ability of DBT t%li%provide three-dimensional images of breast tissue helps radiologists identify lesions more accurately, reducing false-positive and false-negative results.
Healthcare providers are increasingly turning t%li%DBT equipment t%li%enhance their breast cancer screening and diagnostic capabilities. By adopting DBT technology, healthcare facilities can offer their patients a more advanced and comprehensive screening experience, leading t%li%earlier detection of breast cancer and potentially better patient outcomes. Regulatory bodies and healthcare organizations are recognizing the clinical benefits of DBT and incorporating it int%li%breast cancer screening guidelines and recommendations. This growing acceptance and endorsement of DBT as a preferred imaging modality for breast cancer detection further drive its adoption in healthcare settings worldwide.
The rising incidence of breast cancer als%li%underscores the need for continuous innovation and improvement in breast imaging technology. Manufacturers are investing in research and development t%li%enhance the performance and capabilities of digital breast tomosynthesis equipment, focusing on areas such as image resolution, workflow efficiency, and patient comfort. These advancements not only improve the diagnostic accuracy of DBT but als%li%make it more accessible and user-friendly for healthcare providers and patients alike.
Growing Emphasis on Early Detection and Screening Programs
The growing emphasis on early detection and screening programs is a key driver propelling the expansion of the global digital breast tomosynthesis equipment market. Early detection plays a critical role in improving treatment outcomes and survival rates for breast cancer patients, making it a primary focus for healthcare systems worldwide. Screening programs aim t%li%identify breast abnormalities at their earliest stages, when treatment options are most effective, and chances of survival are highest.
Digital breast tomosynthesis (DBT) has emerged as a powerful tool in breast cancer screening due t%li%its ability t%li%provide three-dimensional images of breast tissue with enhanced clarity and detail compared t%li%traditional 2D mammography. The superior sensitivity and specificity of DBT in detecting breast abnormalities contribute t%li%its increasing adoption in screening programs globally. Healthcare organizations, advocacy groups, and governmental agencies are actively promoting breast cancer screening initiatives t%li%raise awareness and encourage early detection among women. These programs often incorporate digital breast tomosynthesis technology as part of their screening protocols, offering patients access t%li%advanced imaging modalities that improve the accuracy and reliability of breast cancer detection.
The integration of DBT int%li%organized screening programs and routine clinical practice has become more widespread as healthcare providers recognize the clinical benefits of this technology. Digital breast tomosynthesis enables radiologists t%li%detect smaller lesions, identify architectural distortions, and reduce false-positive and false-negative findings, leading t%li%more accurate diagnoses and better patient outcomes. In addition t%li%traditional screening programs, there is a growing trend towards personalized screening approaches that take int%li%account individual risk factors and preferences. Digital breast tomosynthesis equipment allows for tailored screening protocols based on a patient's breast density, family history, genetic predisposition, and other relevant factors, optimizing the effectiveness of screening efforts and minimizing unnecessary interventions.
Technological Advancements in Imaging Technology
Technological advancements in imaging technology are playing a pivotal role in driving the growth of the global digital breast tomosynthesis equipment market. As the field of medical imaging continues t%li%evolve, manufacturers are constantly innovating t%li%enhance the capabilities and performance of digital breast tomosynthesis (DBT) equipment, leading t%li%improved diagnostic accuracy and patient outcomes. One of the key technological advancements driving the adoption of digital breast tomosynthesis equipment is the development of higher-resolution imaging sensors and detectors. These advancements enable DBT systems t%li%capture detailed three-dimensional images of breast tissue with greater clarity and precision, enhancing the ability of radiologists t%li%detect subtle abnormalities and lesions.
Advancements in image reconstruction algorithms and processing software have significantly improved the quality of DBT images while reducing noise and artifacts. Sophisticated reconstruction techniques such as iterative reconstruction and model-based algorithms enhance image resolution and contrast, enabling more accurate interpretation of breast images and reducing the likelihood of false-positive and false-negative findings. Another important technological advancement in DBT equipment is the integration of artificial intelligence (AI) and machine learning algorithms. AI-powered image analysis software can automatically detect and highlight suspicious areas on breast images, assisting radiologists in their interpretation and decision-making process. These AI algorithms can als%li%analyze large datasets of breast images t%li%identify patterns and trends, potentially leading t%li%the development of more precise diagnostic tools and predictive models for breast cancer detection.
Also, advancements in ergonomic design and user interface enhancements have made digital breast tomosynthesis equipment more user-friendly and efficient for healthcare providers. Streamlined workflows, intuitive software interfaces, and ergonomic features such as adjustable compression paddles improve the overall user experience and workflow efficiency, enabling radiologists t%li%perform more screenings in less time.
Key Market Challenges
High Initial Setup Costs
One of the primary challenges hindering the adoption of digital breast tomosynthesis equipment is the high initial setup costs associated with acquiring and implementing this technology. Healthcare facilities, particularly in resource-constrained settings, may face budgetary constraints that limit their ability t%li%invest in expensive imaging equipment. The cost of purchasing DBT systems, along with installation, training, and maintenance expenses, can pose a significant financial burden on healthcare providers, impeding the widespread adoption of digital breast tomosynthesis technology.
Reimbursement Issues
Reimbursement policies and coverage for digital breast tomosynthesis procedures vary across different regions and healthcare systems, leading t%li%inconsistencies and uncertainties regarding reimbursement for screening and diagnostic services. In some cases, reimbursement rates may not adequately cover the costs associated with DBT procedures, limiting healthcare providers' incentive t%li%invest in this technology. Additionally, delays or denials in reimbursement approvals can create financial challenges for healthcare facilities, discouraging them from adopting digital breast tomosynthesis equipment.
Regulatory Hurdles
Regulatory approval processes for medical devices, including digital breast tomosynthesis equipment, can be lengthy, complex, and costly. Manufacturers must adhere t%li%stringent regulatory requirements and standards set forth by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) t%li%ensure the safety, efficacy, and quality of their products. Delays in obtaining regulatory approvals or compliance with evolving regulatory requirements can significantly impact product launch timelines and market access, posing challenges for manufacturers seeking t%li%introduce new digital breast tomosynthesis technologies.
Key Market Trends
Increasing Adoption of 3D Mammography
The increasing adoption of 3D mammography is a pivotal factor driving the growth of the global digital breast tomosynthesis (DBT) equipment market. 3D mammography, als%li%known as digital breast tomosynthesis (DBT), has emerged as a preferred imaging modality for breast cancer screening and diagnosis due t%li%its superior capabilities compared t%li%traditional 2D mammography.
3D mammography provides a three-dimensional view of the breast tissue, allowing radiologists t%li%examine breast images layer by layer, thereby improving the detection of breast abnormalities, including small tumors and lesions. This enhanced sensitivity and specificity of 3D mammography in detecting breast cancer have led t%li%its widespread adoption among healthcare providers worldwide. The adoption of 3D mammography is driving the demand for digital breast tomosynthesis equipment, as DBT systems are specifically designed t%li%perform 3D mammography imaging. Healthcare facilities are investing in DBT equipment t%li%upgrade their breast imaging capabilities and offer patients access t%li%advanced screening technologies.
Moreover, the clinical benefits of 3D mammography, including improved cancer detection rates and reduced false-positive findings, are driving market growth. Studies have demonstrated that 3D mammography detects more cancers compared t%li%2D mammography alone while als%li%decreasing the number of false-positive results, leading t%li%more accurate diagnoses and reducing unnecessary follow-up procedures. Regulatory bodies and healthcare organizations are endorsing the use of 3D mammography in breast cancer screening programs, further fueling its adoption. Guidelines from organizations such as the American Cancer Society and the European Society of Breast Imaging recommend the use of DBT as part of routine breast cancer screening for certain patient populations.
Integration with Multimodal Imaging Approaches
The integration of digital breast tomosynthesis (DBT) with multimodal imaging approaches is emerging as a key driver of growth in the global digital breast tomosynthesis equipment market. Multimodal imaging combines the strengths of different imaging modalities, such as ultrasound, magnetic resonance imaging (MRI), and DBT, t%li%provide a more comprehensive evaluation of breast lesions and improve diagnostic accuracy.
By integrating DBT with other imaging modalities, healthcare providers can obtain complementary information about breast tissue morphology, composition, and vascularity, enhancing the diagnostic capabilities of DBT equipment. This integrated approach enables radiologists t%li%better characterize breast lesions, differentiate between benign and malignant lesions, and guide treatment planning.
One of the primary benefits of integrating DBT with multimodal imaging approaches is the ability t%li%overcome the limitations of individual imaging modalities. While DBT excels in detecting architectural distortions and microcalcifications associated with breast cancer, it may have limitations in visualizing certain types of lesions, such as cysts or masses with complex morphologies. By combining DBT with ultrasound or MRI, healthcare providers can obtain additional information about lesion morphology, vascularity, and tissue composition, enhancing diagnostic confidence and reducing the need for additional imaging studies. Multimodal imaging approaches enable more personalized and precise treatment planning for breast cancer patients. By incorporating information from multiple imaging modalities, healthcare providers can tailor treatment strategies based on individual patient characteristics, such as tumor size, location, and histological features. This personalized approach improves treatment outcomes and reduces the risk of undertreatment or overtreatment, leading t%li%better patient care and satisfaction.
The integration of DBT with multimodal imaging approaches als%li%streamlines the diagnostic workflow and improves efficiency in breast imaging centers. Rather than performing separate imaging studies using different modalities, healthcare providers can perform comprehensive evaluations using a single imaging session, saving time and resources for both patients and providers.
Segmental Insights
Product Type Insights
Based on the product type, therapeutics segment emerged as the dominant segment in the global digital breast tomosynthesis equipment market in 2023. This is primarily due t%li%the combined benefits offered by both 2D and 3D mammography technologies, making it a preferred choice among healthcare providers and patients alike. 2D mammography has been the standard screening tool for breast cancer detection for many years, offering reliable results and widespread availability. However, it has limitations, particularly in detecting lesions in dense breast tissue and differentiating between overlapping structures. On the other hand, 3D mammography, or digital breast tomosynthesis (DBT), provides a three-dimensional view of the breast tissue, allowing for better visualization and characterization of breast lesions.
Regional Insights
North America solidified its position as the leading region in the global digital breast tomosynthesis equipment market, capturing the largest market share. This dominance can be attributed t%li%North America's robust healthcare infrastructure, characterized by advanced medical facilities and well-established breast cancer screening programs. With a high level of healthcare expenditure, the region fosters a conducive environment for the adoption of innovative medical technologies, including digital breast tomosynthesis equipment.
Healthcare providers in North America increasingly integrate digital breast tomosynthesis int%li%routine clinical practice, recognizing its effectiveness in detecting breast cancer and reducing false positives. The technology's ability t%li%provide three-dimensional images of the breast improves diagnostic accuracy and enhances the early detection of abnormalities, contributing t%li%better patient outcomes. North America's proactive approach t%li%breast cancer awareness and screening initiatives further drives the adoption of digital breast tomosynthesis equipment. Government-led campaigns and advocacy efforts raise awareness about the importance of early detection, encouraging women t%li%underg%li%regular screenings with advanced imaging technologies.
Key Market Players
- PerkinElmer Inc. (Dexela Ltd.)
- Hologic, Inc
- GE HealthCare Technologies Inc.
- Fujifilm Holdings Corporation
- Siemens Healthineers
- General Medical Merate SpA (IMS GIOTTO SPA)
- Varex Imaging Corporation
- Trivitron Healthcare
- Metaltronica Spa
- Analogic Corporation
In this report, the Global Digital Breast Tomosynthesis Equipment Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- ????????Digital Breast Tomosynthesis Equipment Market, By Product Type:
- Diagnostics
- Therapeutics
- ????????Digital Breast Tomosynthesis Equipment Market, By End-User:
- Hospitals
- Diagnostic Centers
- Other End-Users
- Digital Breast Tomosynthesis Equipment Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
Company Profiles: Detailed analysis of the major companies present in the Global Digital Breast Tomosynthesis Equipment Market.
Available Customizations:
Global Digital Breast Tomosynthesis Equipment Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMERS
5. GLOBAL DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems)
5.2.2. By End-User (Hospitals, Diagnostic Centers, Other End-Users)
5.2.3. By Region
5.2.4. By Company (2023)
5.3. Market Map
5.3.1. By Product Type
5.3.2. By End-User
5.3.3. By Region
6. ASIA PACIFIC DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By End-User
6.2.3. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Digital Breast Tomosynthesis Equipment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By End-User
6.3.2. India Digital Breast Tomosynthesis Equipment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By End-User
6.3.3. Australia Digital Breast Tomosynthesis Equipment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By End-User
6.3.4. Japan Digital Breast Tomosynthesis Equipment Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product Type
6.3.4.2.2. By End-User
6.3.5. South Korea Digital Breast Tomosynthesis Equipment Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product Type
6.3.5.2.2. By End-User
7. EUROPE DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By End-User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Digital Breast Tomosynthesis Equipment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By End-User
7.3.2. Germany Digital Breast Tomosynthesis Equipment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By End-User
7.3.3. Spain Digital Breast Tomosynthesis Equipment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By End-User
7.3.4. Italy Digital Breast Tomosynthesis Equipment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By End-User
7.3.5. United Kingdom Digital Breast Tomosynthesis Equipment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By End-User
8. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By End-User
8.2.3. By Country
8.3. North America: Country Analysis
8.3.1. United States Digital Breast Tomosynthesis Equipment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By End-User
8.3.2. Mexico Digital Breast Tomosynthesis Equipment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By End-User
8.3.3. Canada Digital Breast Tomosynthesis Equipment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By End-User
9. SOUTH AMERICA DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By End-User
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Digital Breast Tomosynthesis Equipment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By End-User
9.3.2. Argentina Digital Breast Tomosynthesis Equipment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By End-User
9.3.3. Colombia Digital Breast Tomosynthesis Equipment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By End-User
10. MIDDLE EAST AND AFRICA DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By End-User
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Digital Breast Tomosynthesis Equipment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By End-User
10.3.2. Saudi Arabia Digital Breast Tomosynthesis Equipment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By End-User
10.3.3. UAE Digital Breast Tomosynthesis Equipment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By End-User
10.3.4. Egypt Digital Breast Tomosynthesis Equipment Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product Type
10.3.4.2.2. By End-User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. PerkinElmer Inc. (Dexela Ltd.)
15.1.1. Company Snapshot
15.1.2. Products & Services
15.1.3. Financials (In case of listed)
15.1.4. Recent Developments
15.1.5. SWOT Analysis
15.2. Hologic, Inc
15.3. GE HealthCare Technologies Inc.
15.4. Fujifilm Holdings Corporation
15.5. Siemens Healthineers
15.6. General Medical Merate SpA (IMS GIOTTO SPA)
15.7. Varex Imaging Corporation
15.8. Trivitron Healthcare
15.9. Metaltronica Spa
15.10. Analogic Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMERS
5. GLOBAL DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems)
5.2.2. By End-User (Hospitals, Diagnostic Centers, Other End-Users)
5.2.3. By Region
5.2.4. By Company (2023)
5.3. Market Map
5.3.1. By Product Type
5.3.2. By End-User
5.3.3. By Region
6. ASIA PACIFIC DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By End-User
6.2.3. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Digital Breast Tomosynthesis Equipment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By End-User
6.3.2. India Digital Breast Tomosynthesis Equipment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By End-User
6.3.3. Australia Digital Breast Tomosynthesis Equipment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By End-User
6.3.4. Japan Digital Breast Tomosynthesis Equipment Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product Type
6.3.4.2.2. By End-User
6.3.5. South Korea Digital Breast Tomosynthesis Equipment Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product Type
6.3.5.2.2. By End-User
7. EUROPE DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By End-User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Digital Breast Tomosynthesis Equipment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By End-User
7.3.2. Germany Digital Breast Tomosynthesis Equipment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By End-User
7.3.3. Spain Digital Breast Tomosynthesis Equipment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By End-User
7.3.4. Italy Digital Breast Tomosynthesis Equipment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By End-User
7.3.5. United Kingdom Digital Breast Tomosynthesis Equipment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By End-User
8. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By End-User
8.2.3. By Country
8.3. North America: Country Analysis
8.3.1. United States Digital Breast Tomosynthesis Equipment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By End-User
8.3.2. Mexico Digital Breast Tomosynthesis Equipment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By End-User
8.3.3. Canada Digital Breast Tomosynthesis Equipment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By End-User
9. SOUTH AMERICA DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By End-User
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Digital Breast Tomosynthesis Equipment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By End-User
9.3.2. Argentina Digital Breast Tomosynthesis Equipment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By End-User
9.3.3. Colombia Digital Breast Tomosynthesis Equipment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By End-User
10. MIDDLE EAST AND AFRICA DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By End-User
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Digital Breast Tomosynthesis Equipment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By End-User
10.3.2. Saudi Arabia Digital Breast Tomosynthesis Equipment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By End-User
10.3.3. UAE Digital Breast Tomosynthesis Equipment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By End-User
10.3.4. Egypt Digital Breast Tomosynthesis Equipment Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product Type
10.3.4.2.2. By End-User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. GLOBAL DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. PerkinElmer Inc. (Dexela Ltd.)
15.1.1. Company Snapshot
15.1.2. Products & Services
15.1.3. Financials (In case of listed)
15.1.4. Recent Developments
15.1.5. SWOT Analysis
15.2. Hologic, Inc
15.3. GE HealthCare Technologies Inc.
15.4. Fujifilm Holdings Corporation
15.5. Siemens Healthineers
15.6. General Medical Merate SpA (IMS GIOTTO SPA)
15.7. Varex Imaging Corporation
15.8. Trivitron Healthcare
15.9. Metaltronica Spa
15.10. Analogic Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
